Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors.
about
Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.Comprehensive analysis of haemostatic profile depending on clinicopathological determinants in breast cancer patients.Tristetraprolin: A novel target of diallyl disulfide that inhibits the progression of breast cancer.Levels of uPA and PAI-1 in breast cancer and its correlation to Ki67-index and results of a 21-multigene-array
P2860
Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Urokinase plasminogen activato ...... raditional prognostic factors.
@ast
Urokinase plasminogen activato ...... raditional prognostic factors.
@en
type
label
Urokinase plasminogen activato ...... raditional prognostic factors.
@ast
Urokinase plasminogen activato ...... raditional prognostic factors.
@en
prefLabel
Urokinase plasminogen activato ...... raditional prognostic factors.
@ast
Urokinase plasminogen activato ...... raditional prognostic factors.
@en
P2093
P2860
P356
P1476
Urokinase plasminogen activato ...... raditional prognostic factors.
@en
P2093
Barbara Jezersek-Novakovic
Darja Arko
Iztok Takac
Maja Lampelj
Maja Ravnik
Nina Cas-Sikosek
Nina Fokter Dovnik
Rajko Kavalar
Sarah Dobnik
P2860
P304
P356
10.2478/RAON-2014-0049
P577
2015-11-27T00:00:00Z